Daiwa Securities Group Inc. Bio N Tech Se Transaction History

Daiwa Securities Group Inc.

$27.1 Billion
Q2 2025

A detailed history of Daiwa Securities Group Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 1,839 shares of BNTX stock, worth $187,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,839

Previous 1,915 3.97%

Holding current value

$187,688

Previous $174,000 12.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$86.65 - $120.54 $6,585 - $9,161	-76 Reduced 3.97%	1,839 $196,000
Q1 2025 May 13, 2025	SELL	$91.06 - $126.88 $2,094 - $2,918	-23 Reduced 1.19%	1,915 $174,000
Q4 2024 Feb 07, 2025	BUY	$99.72 - $122.68 $12,764 - $15,703	128 Added 7.07%	1,938 $221,000
Q3 2024 Nov 12, 2024	SELL	$78.36 - $124.66 $9,011 - $14,335	-115 Reduced 5.97%	1,810 $215,000
Q2 2024 Aug 07, 2024	BUY	$80.36 - $102.87 $125,522 - $160,682	1,562 Added 430.3%	1,925 $155,000
Q1 2024 May 02, 2024	SELL	$88.96 - $112.35 $2,668 - $3,370	-30 Reduced 7.63%	363 $33,000
Q4 2023 Jan 31, 2024	BUY	$90.91 - $112.75 $5,090 - $6,314	56 Added 16.62%	393 $41,000
Q2 2023 Jul 31, 2023	SELL	$102.58 - $129.66 $3,385 - $4,278	-33 Reduced 8.92%	337 $36,000
Q1 2023 May 02, 2023	SELL	$122.57 - $153.67 $254,945 - $319,633	-2,080 Reduced 84.9%	370 $46,000
Q4 2022 Feb 06, 2023	BUY	$118.43 - $186.05 $35,884 - $56,373	303 Added 14.11%	2,450 $368,000
Q3 2022 Nov 02, 2022	BUY	$127.65 - $183.11 $232,195 - $333,077	1,819 Added 554.57%	2,147 $290,000
Q2 2022 Aug 09, 2022	SELL	$123.25 - $186.24 $215,934 - $326,292	-1,752 Reduced 84.23%	328 $49,000
Q1 2022 Apr 29, 2022	BUY	$126.25 - $231.85 $15,781 - $28,981	125 Added 6.39%	2,080 $355,000
Q4 2021 Feb 03, 2022	BUY	$216.64 - $362.52 $14,731 - $24,651	68 Added 3.6%	1,955 $504,000
Q3 2021 Nov 05, 2021	BUY	$205.93 - $447.23 $356,258 - $773,707	1,730 Added 1101.91%	1,887 $515,000
Q2 2021 Aug 06, 2021	BUY	$113.32 - $241.49 $906 - $1,931	8 Added 5.37%	157 $35,000
Q1 2021 May 03, 2021	BUY	$85.73 - $119.5 $2,057 - $2,868	24 Added 19.2%	149 $16,000
Q4 2020 Feb 04, 2021	BUY	$72.71 - $129.54 $9,088 - $16,192	125 New	125 $10,000

Others Institutions Holding BNTX

# of Institutions

321

Shares Held

40.9M

Call Options Held

1.38M

Put Options Held

1.52M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Bio N Tech Se Transaction History